Quality of life assessment is becoming increasingly important in oncology: a paper published in The Lancet Oncology by Andrew Bottomley of the European Organisation for Research and Treatment of Cancer (EORTC) in Brussels, Belgium, and [more]
Relatively low levels of investments from major funders, no recent acceleration in funding observed, and a decline in new commitments to funding since 2011: this is the main – and somehow discouraging – picture of [more]
Cancerworld witnessed the final consensus meeting that produced the new guidelines on advanced breast cancer. The consensus panel gathered in Lisbon during ABC5 to discuss, and sometimes to disagree. At the end, the experts voted more than 50 statements, some of them totally new for the topic [more]
The US restrictions on the prescription of opioids had barely any effect in reducing opioid-related deaths, but are menacing the proper pain management care in cancer patients — and other chronic pain patients, Vera Novais [more]
According to a recent study published in JAMA Oncology, the findings of published meta-analyses on cancer treatments can be recalculated only in 2 cases out of 3. This does not imply that the findings are [more]
When it comes to deciding the age for starting mammography, family history of cancer should count more, according to an analysis of Swedish registries just published in JAMA Oncology. To identify the risk-adapted starting age [more]